Heywang-Köbrunner Sylvia H, Hacker Astrid, Sedlacek Stefan
Referenzzentrum Mammographie München, Germany.
Breast Care (Basel). 2011;6(3):199-207. doi: 10.1159/000329005. Epub 2011 May 27.
Mammography screening is the only method presently considered appropriate for mass screening of asymptomatic women. Its frequent use, however, warrants diligent analysis of potential side effects. Radiation risk is far below the natural yearly risk of breast cancer and should not be used as an argument against screening. False-positive calls lead to additional imaging or histopathological assessment, mainly percutaneous breast biopsy. These measures are tolerated and accepted fairly well. Their number is limited by strict quality assurance and constant training. Interval cancers represent a limitation of breast screening that should prompt further research for optimization. Evaluation of overdiagnosis is a highly debated topic in the literature. According to the probably most realistic available calculations, overdiagnosis is acceptable as it is compensated by the potential mortality reduction. Nonetheless, this potential side effect warrants optimal adjustment of therapy to the patient's individual risk. The mortality reduction seen in randomized studies was confirmed by results from national screening programs. A recent case referent study indicated that improvements in mortality reduction run parallel to improved mammographic techniques. Use of less aggressive therapies is another valuable effect of screening. Awareness of potential problems, strict quality assurance, and further research should help to further develop screening programs.
乳腺钼靶筛查是目前唯一被认为适用于无症状女性群体筛查的方法。然而,其频繁使用需要对潜在副作用进行认真分析。辐射风险远低于乳腺癌的自然年度风险,不应被用作反对筛查的理由。假阳性结果会导致进一步的影像学检查或组织病理学评估,主要是经皮乳房活检。这些措施的耐受性和接受度相当不错。其数量受到严格质量保证和持续培训的限制。间期癌是乳腺筛查的一个局限性,应促使进一步研究以进行优化。过度诊断的评估是文献中一个备受争议的话题。根据可能最现实的现有计算,过度诊断是可以接受的,因为它被潜在的死亡率降低所抵消。尽管如此,这种潜在的副作用仍需要根据患者的个体风险对治疗进行优化调整。随机研究中观察到的死亡率降低得到了国家筛查项目结果的证实。最近一项病例对照研究表明,死亡率降低的改善与乳腺钼靶技术的改进同步。采用侵入性较小的治疗方法是筛查的另一个有益效果。认识到潜在问题、严格的质量保证以及进一步的研究应有助于进一步完善筛查项目。